67 related articles for article (PubMed ID: 18751388)
1. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
2. Abemaciclib is synergistic with doxorubicin in osteosarcoma pre-clinical models via inhibition of CDK4/6-Cyclin D-Rb pathway.
Wang D; Bao H
Cancer Chemother Pharmacol; 2022 Jan; 89(1):31-40. PubMed ID: 34655298
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma.
Wang B; Yu XC; Xu SF; Xu M
J Nanobiotechnology; 2015 Mar; 13():22. PubMed ID: 25880868
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin.
Baranski Z; de Jong Y; Ilkova T; Peterse EF; Cleton-Jansen AM; van de Water B; Hogendoorn PC; Bovée JV; Danen EH
Oncotarget; 2015 Nov; 6(34):36113-25. PubMed ID: 26416351
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcoma.
Meier D; Lodberg A; Gvozdenovic A; Pellegrini G; Neklyudova O; Born W; Fuchs B; Eijken M; M Botter S
Cancer Med; 2021 Jan; 10(1):286-296. PubMed ID: 33179858
[TBL] [Abstract][Full Text] [Related]
6. Emerging Anticancer Potentials of Selenium on Osteosarcoma.
Pang KL; Chin KY
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731474
[TBL] [Abstract][Full Text] [Related]
7. BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines.
Lang C; Stickler S; Rath B; Teufelsbauer M; Weigl L; Hohenegger M; Hamilton G
Anticancer Res; 2024 Mar; 44(3):971-980. PubMed ID: 38423674
[TBL] [Abstract][Full Text] [Related]
8. Enhancing osteosarcoma therapy through aluminium hydroxide nanosheets-enabled macrophage modulation.
Cheng M; Jiang Y; Wang Y; Wu Y; Zhu Y
Int J Pharm; 2024 Jan; 649():123640. PubMed ID: 38043749
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Anti-Cancer Potential of Hispidin: A Comprehensive in Silico and in Vitro Study on Human Osteosarcoma Saos2 Cells.
Benarous K; Serseg T; Mermer A; Tahmasebifar A; Boulebd H; Linani A
Chem Biodivers; 2024 May; 21(5):e202301833. PubMed ID: 38456582
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of Loperamide as a New Drug With Anticancer Activity for Human Osteosarcoma.
Roncuzzi L; Perut F; Baldini N
Anticancer Res; 2024 Mar; 44(3):1063-1070. PubMed ID: 38423641
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress induction by narasin augments doxorubicin's efficacy in osteosarcoma.
Han Z; Yang J; Wang P; Bian F; Jia J
BMC Pharmacol Toxicol; 2023 Oct; 24(1):56. PubMed ID: 37864240
[TBL] [Abstract][Full Text] [Related]
12. In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs.
Zheng Z; Wei X; Lin Y; Tao S; Li H; Ji Z; Wei H; Jin J; Zhao F; Lang C; Liu J; Chen J
J Nanobiotechnology; 2024 Jan; 22(1):29. PubMed ID: 38216937
[TBL] [Abstract][Full Text] [Related]
13. Fructose-mineralized black phosphorus for syncretic bone regeneration and tumor suppression.
Shu J; Wang Y; Zhang G; Shu X; Xu T; Zhang J; Wu F; He J
J Mater Chem B; 2024 May; 12(20):4882-4898. PubMed ID: 38682491
[TBL] [Abstract][Full Text] [Related]
14. Vibrational microspectroscopy as a tool to unveil new chemotherapeutic strategies against osteosarcoma.
Laginha RC; Silva JD; Cinque G; Batista de Carvalho LAE; Batista de Carvalho ALM
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Sep; 317():124389. PubMed ID: 38710137
[TBL] [Abstract][Full Text] [Related]
15. Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines.
Mahbub AA; Le Maitre CL; Haywood-Small SL; Cross NA; Jordan-Mahy N
Cell Death Dis; 2015 Dec; 6(12):e2028. PubMed ID: 26720337
[No Abstract] [Full Text] [Related]
16. Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism.
Ren J; Zhao C; Sun R; Sun J; Lu L; Wu J; Li S; Cui L
Int J Cancer; 2024 May; 154(9):1626-1638. PubMed ID: 38196144
[TBL] [Abstract][Full Text] [Related]
17. The p53-mediated cell cycle regulation is a potential mechanism for emodin-suppressing osteosarcoma cells.
Zhang Q; Hao S; Wei G; Liu X; Miao Y
Heliyon; 2024 Mar; 10(5):e26850. PubMed ID: 38495151
[TBL] [Abstract][Full Text] [Related]
18. Potential Cytoprotective and Anti-Apoptotic Effect of Metamizole Alone and in Combination with Cytostatic Drugs Observed In Vitro in Canine (D-17) and Human (U-2 OS) Osteosarcoma Cell Lines.
Poradowski D; Chrószcz A; Spychaj R; Onar V
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540184
[TBL] [Abstract][Full Text] [Related]
19. Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy.
Welch DL; Fridley BL; Cen L; Teer JK; Yoder SJ; Pettersson F; Xu L; Cheng CH; Zhang Y; Alexandrow MG; Xiang S; Robertson-Tessi M; Brown JS; Metts J; Brohl AS; Reed DR
Sci Rep; 2023 Nov; 13(1):20125. PubMed ID: 37978271
[TBL] [Abstract][Full Text] [Related]
20. The Oncolytic Effect of Aerva lanata on Osteosarcoma Cell Lines via the Apoptotic Signaling Pathway.
Zuvairiya U; S M; Jayaraman S; Suresh V
Cureus; 2024 Apr; 16(4):e58091. PubMed ID: 38738026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
